Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MDXG

+ Watchlist+ Portfolio

MiMedx Group, Inc

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$3.18
52-Week Range
$3.03 – $7.45
Market Cap
$464.04M
P/E (TTM)
—
EPS (TTM)
-0.13
Dividend Yield
0.00%
Advanced Metrics
Price/Book
2.20
PEG Ratio
2.88
Return on Equity
-8.53%
Return on Assets
-5.39%
Gross Margin
77.29%
Operating Margin
-8.28%
Profit Margin
-6.32%
Current Ratio
4.35
Debt/Equity
—
Total Debt
$0.00
Free Cash Flow
$26.70M
Revenue Growth
-45.20%
Earnings Growth
—
Enterprise Value
$343.25M

Market Snapshot

About

MiMedx Group, Inc. is a biopharmaceutical company focused on developing and distributing regenerative and therapeutic biologics utilizing human placental tissue allografts. The company provides advanced wound care and surgical products derived from amniotic tissue for applications in wound care, orthopedics, spine, and sports medicine.